Data coverage
The goal of the project is to identify recurrent genetic alterations (mutations, deletions, amplifications, rearrangements) and/or gene expression signatures. National Cancer Institute (NCI) utilized whole genome sequencing and/or whole exome sequencing in conjunction with transcriptome sequencing. The samples were processed and submitted for genomic characterization using pipelines and procedures established within The Cancer Genome Analysis (TCGA) project.
Access & permitted use
Review the publisher’s documentation for availability, eligibility and permitted uses, including commercial analysis, model training and redistribution.
NIH Genomic Data Sharing Policy: https://gdc.cancer.gov/access-data/data-access-policies
Need help sourcing data?
Tell us your required fields, population, geography and time period. We can review suitable sources and licensing options.
Request sourcing help